Publicações

The Vascular Targeting Agent Combretastatin-A4 and a Novel Cis-Restricted Β-Lactam Analogue, Ca-432, Induce Apoptosis in Human Chronic Myeloid Leukemia Cells and Ex Vivo Patient Samples Including Those Displaying Multidrug Resistance

AuthID
P-009-FEK

Author(s)

Greene, LM

Nathwani, SM

Bright, SA

Fayne, D

Croke, A

Gagliardi, M

McElligott, AM

O'Connor, L

Carr, M

Keely, NO

O'Boyle, NM

Carroll, P

Sarkadi, B

Conneally, E

Lloyd, DG

Lawler, M

Meegan, MJ

Zisterer, DM

Tipo de Documento

Article

Year published

2010

Publicado

in Journal of Pharmacology and Experimental Therapeutics, ISSN: 0022-3565

Volume: 335, Número: 2, Páginas: 302-313

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1124/jpet.110.170415

Pubmed: 20699436

SCOPUS: 2-s2.0-78149279339

Source Identifiers

ISSN: 0022-3565

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

The Vascular Targeting Agent Combretastatin-A4 and a Novel Cis-Restricted Β-Lactam Analogue, Ca-432, Induce Apoptosis in Human Chronic Myeloid Leukemia Cells and Ex Vivo Patient Samples Including Those Displaying Multidrug Resistance

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

The Vascular Targeting Agent Combretastatin-A4 and a Novel Cis-Restricted Β-Lactam Analogue, Ca-432, Induce Apoptosis in Human Chronic Myeloid Leukemia Cells and Ex Vivo Patient Samples Including Those Displaying Multidrug Resistance

Links Úteis

Ajuda